ACADIA Pharmaceuticals, Inc. (ACAD)
27.76
-0.07
(-0.25%)
USD |
NASDAQ |
Dec 24, 10:39
ACADIA Pharmaceuticals SG&A Expense (TTM): 523.36M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| ADMA Biologics, Inc. | 96.37M |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Amicus Therapeutics, Inc. | 353.07M |
| Soleno Therapeutics, Inc. | 128.55M |